Athersys (ATHX) Tops Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. SPY
4. ATH
5. PTC
6. CME
7. USO
8. AMD
9. EVTL
10. KLC

Go back to Athersys (ATHX) Tops Q4 EPS by 2c

Athersys Announces Financial Results for Fourth Quarter and Full Year 2019

March 16, 2020 4:05 PM EDT

Clinical trial results in Acute Respiratory Distress Syndrome (ARDS) supported Fast Track designation by FDA and designation by the Biomedical Advanced Research and Development Authority (BARDA) as a "Highly Relevant" program for COVID-19 and other pathogens

Management to host conference call at 4:30 PM EST today

CLEVELAND--(BUSINESS WIRE)-- Athersys, Inc. (NASDAQ: ATHX) announced today its fourth quarter 2019 and annual 2019 financial results and recent highlights.

Throughout all of 2019, we made important progress in our key clinical... More